PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.690.03 (-4.17%)
0.68 - 0.75
0.33 - 0.86
18.34M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-25.95%
Negative revenue growth while 0259.HK stands at 35.55%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-48.58%
Negative gross profit growth while 0259.HK is at 106.96%. Joel Greenblatt would examine cost competitiveness or demand decline.
-122.15%
Negative EBIT growth while 0259.HK is at 7133.85%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-122.15%
Negative operating income growth while 0259.HK is at 1257.57%. Joel Greenblatt would press for urgent turnaround measures.
-112.71%
Negative net income growth while 0259.HK stands at 14.34%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-111.92%
Negative EPS growth while 0259.HK is at 9.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-111.92%
Negative diluted EPS growth while 0259.HK is at 9.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
5.84%
Slight or no buybacks while 0259.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
5.85%
Slight or no buyback while 0259.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-1.18%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
21.66%
OCF growth under 50% of 0259.HK's 212.85%. Michael Burry might suspect questionable revenue recognition or rising costs.
22.08%
FCF growth under 50% of 0259.HK's 108.20%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-40.24%
Negative 10Y revenue/share CAGR while 0259.HK stands at 97.41%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-52.05%
Negative 5Y CAGR while 0259.HK stands at 33.22%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.63%
3Y revenue/share CAGR at 75-90% of 0259.HK's 23.58%. Bill Ackman would expect new product strategies to close the gap.
-6853.77%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-29.54%
Negative 5Y OCF/share CAGR while 0259.HK is at 341.80%. Joel Greenblatt would question the firm’s operational model or cost structure.
-75.23%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-114.02%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-118.06%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-148.19%
Negative 3Y CAGR while 0259.HK is 42.89%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
90.48%
10Y equity/share CAGR above 1.5x 0259.HK's 39.92%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-2.50%
Negative 5Y equity/share growth while 0259.HK is at 46.91%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
38.48%
3Y equity/share CAGR 1.25-1.5x 0259.HK's 33.57%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-24.01%
Cut dividends over 10 years while 0259.HK stands at 299.98%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-60.78%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-60.06%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-20.45%
Firm’s AR is declining while 0259.HK shows 8.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.44%
Inventory shrinking or stable vs. 0259.HK's 33.23%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-4.93%
Negative asset growth while 0259.HK invests at 9.61%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
8.83%
1.25-1.5x 0259.HK's 6.70%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
7.92%
Debt growth far above 0259.HK's 15.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
15.24%
R&D growth of 15.24% while 0259.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-27.52%
We cut SG&A while 0259.HK invests at 13.93%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.